Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LXRX

Lexicon Pharmaceuticals Inc

2.55

Jun 26 • 04:00PM ET +0.26 (11.35%)

Healthcare Biotechnology USA Small NASD

Peers: KYMR NUVL RYTM INCY KRYS VKTX BMRN AXSM MDGL NBIX

| Held by: VTI VXF SCHA XPH VHT PRFZ BBC RSSL SCHB QQQS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.07	Insider Own	51.75%	Shs Outstand	423.77M	Perf Week	26.87%
Market Cap	1.13B	Forward P/E	-	EPS next Y	-0.21	Insider Trans	0.90%	Shs Float	214.31M	Perf Month	17.51%
Enterprise Value	1.02B	PEG	-	EPS next Q	-0.05	Inst Own	29.26%	Short Float	11.86%	Perf Quarter	56.44%
Income	-26.09M	P/S	16.27	EPS this Y	-13.33%	Inst Trans	9.83%	Short Ratio	10.20	Perf Half Y	110.74%
Sales	69.64M	P/B	5.33	EPS next Y	-30.01%	ROA	-9.21%	Short Interest	25.43M	Perf YTD	121.74%
Book/sh	0.48	P/C	6.64	EPS next 5Y	12.50%	ROE	-16.01%	52W High	2.53 0.79%	Perf Year	174.40%
Cash/sh	0.38	P/FCF	-	EPS past 3/5Y	39.13% 23.47%	ROIC	-10.08%	52W Low	0.80 218.51%	Perf 3Y	17.51%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	610.25% 15.72%	Gross Margin	98.70%	Volatility	7.95% 6.42%	Perf 5Y	-55.42%
Dividend TTM	-	EV/Sales	14.64	EPS Y/Y TTM	86.10%	Oper. Margin	-34.79%	ATR (14)	0.14	Perf 10Y	-81.32%
Dividend Ex-Date	-	Quick Ratio	18.77	Sales Y/Y TTM	123.12%	Profit Margin	-37.46%	RSI (14)	76.20	Recom	1.80
Dividend Gr. 3/5Y	- -	Current Ratio	18.79	EPS Q/Q	96.28%	SMA20	25.68%	Beta	1.04	Target Price	3.77
Payout	-	Debt/Eq	0.28	Sales Q/Q	1572.11%	SMA50	29.00%	Rel Volume	15.80	Prev Close	2.29
Employees	81	LT Debt/Eq	0.28	Earnings	May 07 BMO	SMA200	64.21%	Avg Volume	2.49M	Price	2.55
IPO	Apr 07, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	100.00% 115.55%	Trades		Volume	39,381,212	Change	11.35%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)